Donors after cardiac death (DCD) could increase the organ pool. Data supports good long-term renal graft survival. However, DCDs are <10% of deceased donors in the United States, due to delayed graft function, and primary nonfunction. These complications are minimized by extracorporeal support after cardiac death (ECS-DCD). This study assesses immediate and acute renal function from different donor types. DCDs kidneys were recovered by conventional rapid recovery or by ECS, and transplanted into nephrectomized healthy swine. Warm ischemia of 10 and 30 min were evaluated. Swine living donors were controls (LVD). ECSDCDs were treated with 90 min of perfusion until organ recovery. After procurement, kidneys were cold storage 4-6 h. Renal vascular resistance (RVR), urine output (UO), urine protein concentration (UrPr) and creatinine clearance (CrCl), were collected during 4 h posttransplantation. All grafts functioned with adequate renal blood flow for 4 h. RVR at 4 h posttransplant returned to baseline only in the LVD group (0.36 mmHg/mL/min ± 0.03). RVR was higher in all DCDs (0.66 mmHg/mL/min ± 0.13), without differences between them. UO was >50 mL/h in all DCDs, except in DCD-30 (6.8 mL/h ± 1.7). DCD-30 had lower CrCl (0.9 mL/min ± 0.2) and higher UrPr >200 mg/dL, compared to other DCDs >10 mL/min and <160 mg/dL, respectively. Normothermic ECS can resuscitate kidneys to transplantable status after 30 min of cardiac arrest/WI.
The use of organs recovered from donors following circulatory determination of death (DCD)-previously known as non-heart beating donors-has the potential to increase the donor pool; but currently accounts for less than 8% of all organ transplants (2). The reason is that organs taken by 'rapid recovery' from DCD donors do not function as well as organs from DND, especially initially. Poor immediate graft function can be tolerated for renal transplants because of renal replacement therapies like dialysis, so almost all organs from DCD are kidneys. The incidence of delayed graft function and primary graft nonfunction for kidneys from DCD is significantly higher than kidneys from DND, in some series more than double
. This is presumed to be due to the warm ischemic and hypoxic injury that inevitably occurs following withdrawal of life support until the organs are cold perfused. (6, 7) . By restarting circulation after cardiac arrest, the agonal, hypoxic and ischemic events surrounding death and subsequent reperfusion can be turned into an ischemic preconditioning phenomenon (8) .
The use of normothermic venoarterial extracorporeal membrane oxygenation support (hereafter called ECS) after cardiac arrest restores circulation of warm oxygenated blood to the abdominal organs. It can be initiated immediately following declaration of death. Experimental data from our lab has shown that kidney and liver function returns and is maintained while on ECS (5). In animals, perfusing with warm oxygenated blood has been shown experimentally to increase the energy charge (ADP) and antioxidant levels in the recovered organs
In our clinical experience the donor pool was expanded by 33% by establishing normothermic, oxygenated blood perfusion of abdominal organs using ECS shortly after circulatory determination of death. Moreover it allowed for controlled, unhurried organ procurement; delayed graft function was developed in only two grafts (8%) (9) . 
Material and Methods
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Data acquisition
Data collected during the experiment are summarized in Table 2 . Baseline (BL) data were collected on the single recipient kidney after surgical instrumentation but before implantation of renal grafts.
Data analysis
Renal vascular resistance (RVR) was calculated using the following equation: RVR = (MAP-CVP)/RAF. Creatinine clearance (mL/min) was calculated using the following equation: CrCl = ([U] × (UO/60))/[P], in which [U] = urine concentration of creatinine, [P]
= plasma concentration of creatinine, and UO = urine output in mL/h. Urine was collected continuously from the ureter, during the total length of the study (4 h Urine Output is represented in Figure 5 . Although all groups had some urine output, the amount produced in the DCD-30 min group was minimal (6.8 ± 1.7 mL/h), and significantly less than in the other groups that all had urine output of more than 50 mL/h by the fourth hour. Figure 7 . 
Renal hemodynamics and function Renal artery flow (RAF) following transplantation was higher at the end of the experiment in the group that received grafts from LVD (p < 0.05) compared to all DCD groups (Figure 3). RAF was lower only in the DCD-10 min group through all the experimental time, compared to other DCD groups.
As expected renal vascular resistance (RVR) Figure 4, correlated with RAF. It increased significantly immediately after reperfusion in all groups due to cold preservation, and returned to normal only in the LVD group (p < 0.05). In the other four groups, RVR was slightly higher than normal, baseline values during the whole experiment, without significant differences between them.
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Creatinine Clearance (CrCl) is represented in Figure 6: CrCl was significantly lower (p < 0.05) in the DCD-30 group 0.9 ± 0.2 mL/min, compared to the other groups after 1-h posttransplant. Only grafts from the LVD group returned back to normal values (∼25 mL/min) after 4 h of reperfusion. The DCD-30 min group had significantly lower CrCl at 1 and 4-h posttransplantation, compared to all the groups. In particular, when ECS support was used, after 30 min of warm ischemia (ECS-DCD 30 min), the CrCl was similar to those DCD that sustained only 10 min of warm ischemia.
Urine protein concentration (UrPr) at 1 and 4 h following reperfusion is represented in
Renal pathology A summary of the pathologic findings from renal tissue collected at the end of the experiment can be found in
Discussion
The increasing gap between organ demand and organ sources has led the medical community to go back to the 
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out of 32 kidneys) but similar long-term survival rates compared to other type of donors (29). The transplant group from The National Taiwan University Hospital, used VA perfusion with oxygenation (ECS) at 4
• C. They reported 66% of immediate graft function, and 33% incidence of DGF that resolved with short-term (1-2 weeks) hemodialysis therapy (30) (31) (32) . A group from Japan used rapid cooling techniques to procure organs from DCD obtaining similar results (12, 20, 32, 33) .
A transplant group in Spain has reported using normothermic ECMO perfusion to support the potential donor until organ procurement (34). In 2000, Valero et al. reported significantly lower rates of DGF (13%) and no PGNF in kidneys from DCD when ECMO was used during organ donation in DCD (21). Our group at the University of Michigan Hospital, uses normothermic ECMO in DCD Maastricht type II and IV donors and reported low rates of DGF (8%), no
PGNF, and an increment of the organ pool at our institution by 33% (9, 21, 35 
